Cargando…
Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report
A 23-year-old male presented with a 3-month history of left purulent rhinorrhea, progressive nasal obstruction, and intermittent epistaxis. A fiberoptic examination revealed a large vascular polypoid mass completely filling the left nasal cavity. CT and MRI scans showed a large hypervascular mass in...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301122/ https://www.ncbi.nlm.nih.gov/pubmed/28203170 http://dx.doi.org/10.1159/000455040 |
_version_ | 1782506304913276928 |
---|---|
author | Suzuki, Tomoharu Yasumatsu, Ryuji Nakashima, Torahiko Arita, Shuji Yamamoto, Hidetaka Nakagawa, Takashi |
author_facet | Suzuki, Tomoharu Yasumatsu, Ryuji Nakashima, Torahiko Arita, Shuji Yamamoto, Hidetaka Nakagawa, Takashi |
author_sort | Suzuki, Tomoharu |
collection | PubMed |
description | A 23-year-old male presented with a 3-month history of left purulent rhinorrhea, progressive nasal obstruction, and intermittent epistaxis. A fiberoptic examination revealed a large vascular polypoid mass completely filling the left nasal cavity. CT and MRI scans showed a large hypervascular mass involving the left nasal airway, maxillary antrum, and the anterior ethmoid cells. There was no bony erosion or contiguous spread, and the remaining sinuses, orbit, and cranial fossa were uninvolved. The patient underwent complete removal of the mass via an external lateral rhinotomy approach. The soft mass was large and vascular. A microscopic analysis revealed an undifferentiated tumor consisting of a solid sheet of small, round blue cells. Mitotic figures were also present. Immunohistochemically, the tumor cells were strongly positive for CD99. Molecular studies using a PCR confirmed the chromosomal translocation of FLI1 (exon 6). These findings were considered diagnostic for Ewing's sarcoma. Postoperatively, the patient was treated with combined chemotherapy and radiotherapy. Adjuvant chemotherapy consisting of vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide (total: 7 cycles) was commenced. He also received radiation therapy for local control (total dose: 50.4 Gy). The patient is currently alive without any evidence of recurrence or metastasis. |
format | Online Article Text |
id | pubmed-5301122 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | S. Karger AG |
record_format | MEDLINE/PubMed |
spelling | pubmed-53011222017-02-15 Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report Suzuki, Tomoharu Yasumatsu, Ryuji Nakashima, Torahiko Arita, Shuji Yamamoto, Hidetaka Nakagawa, Takashi Case Rep Oncol Case Report A 23-year-old male presented with a 3-month history of left purulent rhinorrhea, progressive nasal obstruction, and intermittent epistaxis. A fiberoptic examination revealed a large vascular polypoid mass completely filling the left nasal cavity. CT and MRI scans showed a large hypervascular mass involving the left nasal airway, maxillary antrum, and the anterior ethmoid cells. There was no bony erosion or contiguous spread, and the remaining sinuses, orbit, and cranial fossa were uninvolved. The patient underwent complete removal of the mass via an external lateral rhinotomy approach. The soft mass was large and vascular. A microscopic analysis revealed an undifferentiated tumor consisting of a solid sheet of small, round blue cells. Mitotic figures were also present. Immunohistochemically, the tumor cells were strongly positive for CD99. Molecular studies using a PCR confirmed the chromosomal translocation of FLI1 (exon 6). These findings were considered diagnostic for Ewing's sarcoma. Postoperatively, the patient was treated with combined chemotherapy and radiotherapy. Adjuvant chemotherapy consisting of vincristine, doxorubicin, and cyclophosphamide alternating with ifosfamide and etoposide (total: 7 cycles) was commenced. He also received radiation therapy for local control (total dose: 50.4 Gy). The patient is currently alive without any evidence of recurrence or metastasis. S. Karger AG 2017-01-19 /pmc/articles/PMC5301122/ /pubmed/28203170 http://dx.doi.org/10.1159/000455040 Text en Copyright © 2017 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc/4.0/ This article is licensed under the Creative Commons Attribution-NonCommercial-4.0 International License (CC BY-NC) (http://www.karger.com/Services/OpenAccessLicense). Usage and distribution for commercial purposes requires written permission. |
spellingShingle | Case Report Suzuki, Tomoharu Yasumatsu, Ryuji Nakashima, Torahiko Arita, Shuji Yamamoto, Hidetaka Nakagawa, Takashi Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
title | Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
title_full | Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
title_fullStr | Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
title_full_unstemmed | Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
title_short | Primary Ewing's Sarcoma of the Sinonasal Tract: A Case Report |
title_sort | primary ewing's sarcoma of the sinonasal tract: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5301122/ https://www.ncbi.nlm.nih.gov/pubmed/28203170 http://dx.doi.org/10.1159/000455040 |
work_keys_str_mv | AT suzukitomoharu primaryewingssarcomaofthesinonasaltractacasereport AT yasumatsuryuji primaryewingssarcomaofthesinonasaltractacasereport AT nakashimatorahiko primaryewingssarcomaofthesinonasaltractacasereport AT aritashuji primaryewingssarcomaofthesinonasaltractacasereport AT yamamotohidetaka primaryewingssarcomaofthesinonasaltractacasereport AT nakagawatakashi primaryewingssarcomaofthesinonasaltractacasereport |